As of June 18, 2025, Zevotek Inc (ZVTK) reports a ROE (Return on Equity) of 59.91%.
ROE (Return on Equity) measures how well a company generates profits from shareholders' investments, indicating equity efficiency.
Historical Trend of Zevotek Inc's ROE (Return on Equity)
Over recent years, Zevotek Inc's ROE (Return on Equity) has shown significant volatility. The table below summarizes the historical values:
| Date | ROE (Return on Equity) |
|---|---|
| 2012-06-30 | 59.91% |
| 2011-06-30 | 115.52% |
| 2010-06-30 | 92.08% |
| 2009-06-30 | 58.01% |
| 2008-06-30 | 154.54% |
This fluctuation highlights how Zevotek Inc manages its efficiency in generating profits from shareholders' equity over time.
Comparing Zevotek Inc's ROE (Return on Equity) to Peers
To better understand Zevotek Inc's position, it's useful to compare its ROE (Return on Equity) against industry peers. Below are selected comparisons:
| Company | ROE (Return on Equity) |
|---|---|
| Zevotek Inc (ZVTK) | 59.91% |
| Psycheceutical Bioscience Inc (BWVI) | 37649.31% |
| United World Holding Group Ltd (UWHGF) | 570.22% |
| Sunburst Acquisitions V Inc (SGIL) | 320.71% |
| New Leaf Ventures Inc (NLV.CN) | 259.80% |
| Eurotech Ltd (EUOT) | 254.25% |
Compared to its competitors, Zevotek Inc's ROE (Return on Equity) is about average compared to peers, reflecting standard industry returns on equity investment.